The US Food and Drug Administration (FDA) has approved Allergan’s drug-releasing implant, Durysta, for administration within the cavities of the eye to reduce intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
FDA
Mojo Vision Develops Augmented Reality Screen on a Contact Lens
Mojo Vision is revealing a smart contact lens with a tiny built-in display that lets you view augmented reality images on a screen.
First FDA Approved Contact Lens to Slow Childhood Nearsightedness Coming in March
The FDA has approved its first contact lens designed to effectively slow the progression of nearsightedness in children, starting in ages 8 to 12.
doctors Are Now Performing Eye Surgery with Newly FDA Approved Lens
A Las Vegas doctor is changing the way patients view their world — he’s doing it through a new surgery with lenses just approved by the FDA.
FDA Approves Hydrus Microstent for Glaucoma Surgery
The US Food and Drug Administration (FDA) has approved the Hydrus Microstent, a device used for microinvasive glaucoma surgery (MIGS) in patients with mild to moderate primary open-angle glaucoma, in conjunction with cataract surgery.
Glaukos Gets FDA Approval for Glaucoma Treatment
Glaukos has just received FDA approval for its iStent inject Trabecular Micro-Bypass System indicated for the reduction of intraocular pressure in primary open-angle glaucoma patients undergoing concomitant cataract surgery.
Artificial Iris Implant Gets Approval from FDA
The Food and Drug Administration has approved the first artificial iris implant in the United States called the CustomFlex Artificial Iris. The implant will benefit patients with missing or damaged irises due to aniridia, traumatic injury, albinism, and melanoma.
New Stem cell Therapy is Now FDA Compliant in the United States
Dr. Jeffrey N. Weiss, a physician, retinal specialist and electrical engineer did his first ocular retinal stem cell surgery in Germany and now it is FDA compliant in the United States.
You must be logged in to post a comment.